Education
About Us
Working with TipRanks
Follow Us
Corbion NV (NL:CRBN)
:CRBN
CRBN Stock Chart & Stats
€18.78
-€0.72(-3.46%)
At close: 4:00 PM EST
€18.78
-€0.72(-3.46%)
Day’s Range― - ―
52-Week Range€16.16 - €21.64
Previous CloseN/A
Volume184.39K
Average Volume (3M)126.91K
Market Cap
€1.10B
Enterprise Value€1.54B
Total Cash (Recent Filing)€44.70M
Total Debt (Recent Filing)€481.10M
Price to Earnings (P/E)14.4
Beta0.83
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.5%
Share Statistics
EPS (TTM)0.56
Shares Outstanding58,250,310
10 Day Avg. Volume117,838
30 Day Avg. Volume126,914
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.45
Price to Sales (P/S)0.85
P/FCF Ratio11.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€23.80Price Target Upside26.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.46
Revenue Forecast (FY)€1.30B
Bulls Say, Bears Say
Bulls Say
Specialty B2B Ingredient FranchiseCorbion's core business supplies lactic-acid–based ingredients and shelf-life solutions to food manufacturers and industrial customers. This B2B, specialty-ingredient model drives structural, repeatable demand, supports higher-margin product mix, and benefits from long qualification cycles that create durable customer relationships.
Material Debt ReductionSignificant deleveraging over two years meaningfully lowers financial risk and interest burden, improving flexibility for capex, R&D or dividend support. A stronger balance sheet also enhances resilience through cycles and gives management options for strategic investments or bolt-on M&A.
Recovered Cash GenerationConsistent positive operating cash flow and a return to positive free cash flow after earlier deficits signal improved cash discipline. Reliable cash generation underpins reinvestment, supports dividends and debt reduction, and provides a durable buffer against earnings cyclicality.
Bears Say
Multi-year Revenue SoftnessA multi-year top-line decline erodes operating leverage and constrains the company's ability to grow margins or fund strategic initiatives organically. Persistent revenue weakness increases reliance on cost actions or one-time items to sustain profitability and limits long-term earnings visibility.
Volatile Net IncomeMarked swings in net income reduce forecast reliability and suggest exposure to one-offs or uneven cost absorption. Profit volatility complicates capital allocation, undermines confidence in sustainable margins, and makes long-term cash return planning (dividends, buybacks) less predictable.
Asset Contraction And FCF VariabilityA shrinking asset base alongside fluctuating free cash flow signals constrained reinvestment capacity or portfolio resizing. This can limit long-term growth options, reduce economies of scale, and increase sensitivity to demand swings, weakening the firm's ability to sustain structural expansion.
Corbion NV News
CRBN FAQ
What was Corbion NV’s price range in the past 12 months?
Corbion NV lowest stock price was €16.16 and its highest was €21.64 in the past 12 months.
What is Corbion NV’s market cap?
Corbion NV’s market cap is €1.10B.
When is Corbion NV’s upcoming earnings report date?
Corbion NV’s upcoming earnings report date is Aug 06, 2026 which is in 143 days.
How were Corbion NV’s earnings last quarter?
Corbion NV released its earnings results on Feb 26, 2026. The company reported €0.561 earnings per share for the quarter, beating the consensus estimate of N/A by €0.561.
Is Corbion NV overvalued?
According to Wall Street analysts Corbion NV’s price is currently Undervalued.
Does Corbion NV pay dividends?
Corbion NV pays a Annually dividend of €0.64 which represents an annual dividend yield of 3.5%. See more information on Corbion NV dividends here
What is Corbion NV’s EPS estimate?
Corbion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corbion NV have?
Corbion NV has 58,250,310 shares outstanding.
What happened to Corbion NV’s price movement after its last earnings report?
Corbion NV reported an EPS of €0.561 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.062%.
Which hedge fund is a major shareholder of Corbion NV?
Currently, no hedge funds are holding shares in NL:CRBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Corbion NV
Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.
CRBN Stock 12 Month Forecast
Average Price Target
€23.80
▲(26.73% Upside)
Technical Analysis
Options Prices
Currently, No data available
---